FGP
Freestone Grove Partners Portfolio holdings
AUM
$15.6B
Turnover
60.27%
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter
Est. Return
+0.81%
1 Year Est. Return
+27.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.2B
AUM Growth
+$326M
(+2.4%)
Cap. Flow
+$206M
Cap. Flow
% of AUM
1.46%
Top 10 Holdings %
Top 10 Hldgs %
19%
Holding
1,229
New
515
Increased
214
Reduced
228
Closed
267
Avg Time Held Equity + Options
0.3
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.1
years
Avg Time Held Equity only
0.3
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$134M |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$120M |
| 3 |
KKR & Co
KKR
|
+$113M |
| 4 |
Mondelez International
MDLZ
|
+$103M |
| 5 |
AXIS Capital
AXS
|
+$97.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$303M |
| 2 |
Boston Scientific
BSX
|
+$127M |
| 3 |
Lennar Class A
LEN
|
+$95.9M |
| 4 |
Martin Marietta Materials
MLM
|
+$94.6M |
| 5 |
Colgate-Palmolive
CL
|
+$92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.98% |
| 2 | Technology | 14.39% |
| 3 | Miscellaneous | 12.72% |
| 4 | Industrials | 12.27% |
| 5 | Healthcare | 11.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
751
Somnigroup International
SGI
$14.3B
| $174K | ﹤0.01% |
+2,360
| New | +$205K |
2026 Q1
0 quarters
|
|
752
Loar Holdings
LOAR
$5.69B
| $173K | ﹤0.01% |
3,024
+8
| +0.3% | +$540 |
2025 Q2
3 quarters
|
|
753
Entegris
ENTG
$23.3B
| $172K | ﹤0.01% |
1,467
-6,561
| -82% | -$776K |
2025 Q4
1 quarter
|
|
754
S&T Bancorp
STBA
$1.69B
| $172K | ﹤0.01% |
+4,110
| New | +$172K |
2026 Q1
0 quarters
|
|
755
Cracker Barrel
CBRL
$1.39B
| $169K | ﹤0.01% |
6,017
-20,062
| -77% | -$611K |
2025 Q4
1 quarter
|
|
756
NerdWallet
NRDS
$604M
| $168K | ﹤0.01% |
+16,137
| New | +$182K |
2026 Q1
0 quarters
|
|
757
Keysight
KEYS
$61.1B
| $167K | ﹤0.01% |
+592
| New | +$148K |
2026 Q1
0 quarters
|
|
758
Enovix
ENVX
$520M
| $166K | ﹤0.01% |
32,136
-11,955
| -27% | -$74.8K |
2025 Q3
2 quarters
|
|
759
Stryker
SYK
$108B
| $162K | ﹤0.01% |
+493
| New | +$177K |
2026 Q1
0 quarters
|
|
760
USA Today Co
TDAY
$1.02B
| $161K | ﹤0.01% |
+22,896
| New | +$140K |
2026 Q1
0 quarters
|
|
761
ACV Auctions
ACVA
$1.78B
| $160K | ﹤0.01% |
+37,799
| New | +$247K |
2026 Q1
0 quarters
|
|
762
Inspire Medical Systems
INSP
$1.96B
| $156K | ﹤0.01% |
+3,021
| New | +$211K |
2026 Q1
0 quarters
|
|
763
Janus International
JBI
$559M
| $154K | ﹤0.01% |
29,825
-72,567
| -71% | -$470K |
2025 Q4
1 quarter
|
|
764
DELISTED
American Express Global Business Travel
GBTG
| $152K | ﹤0.01% |
+27,328
| New | +$170K |
2026 Q1
0 quarters
|
|
765
Sarepta Therapeutics
SRPT
$1.78B
| $151K | ﹤0.01% |
+6,920
| New | +$134K |
2026 Q1
0 quarters
|
|
766
Telephone and Data Systems
TDS
$3.85B
| $150K | ﹤0.01% |
+3,555
| New | +$156K |
2026 Q1
0 quarters
|
|
767
Barrett Business Services
BBSI
$772M
| $150K | ﹤0.01% |
+5,128
| New | +$169K |
2026 Q1
0 quarters
|
|
768
Rogers Corp
ROG
$2.51B
| $149K | ﹤0.01% |
+1,384
| New | +$142K |
2026 Q1
0 quarters
|
|
769
Blue Bird Corp
BLBD
$1.94B
| $147K | ﹤0.01% |
2,596
-7,676
| -75% | -$414K |
2025 Q4
1 quarter
|
|
770
MillerKnoll
MLKN
$1.44B
| $147K | ﹤0.01% |
+10,191
| New | +$200K |
2026 Q1
0 quarters
|
|
771
Winmark
WINA
$1.09B
| $145K | ﹤0.01% |
+339
| New | +$150K |
2026 Q1
0 quarters
|
|
772
Casella Waste Systems
CWST
$5.2B
| $144K | ﹤0.01% |
+1,818
| New | +$174K |
2026 Q1
0 quarters
|
|
773
Madison Square Garden
MSGE
$3.76B
| $144K | ﹤0.01% |
+2,440
| New | +$144K |
2026 Q1
0 quarters
|
|
774
Interface
TILE
$2.02B
| $141K | ﹤0.01% |
+5,656
| New | +$169K |
2026 Q1
0 quarters
|
|
775
Illumina
ILMN
$40.7B
| $137K | ﹤0.01% |
+1,112
| New | +$146K |
2026 Q1
0 quarters
|
|
Similar funds
ECM
MIFH
GF
AIM
OTPPB
AA
IWC
Freestone Grove Partners's Q1 2026 Portfolio in Review
As of Q1 2026, Freestone Grove Partners held 1,229 positions worth $14.2B, up 2.4% from $13.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Freestone Grove Partners's Q1 2026 filing shows 515 new, 214 increased, 228 reduced and 267 closed positions. Its largest new stake was Citigroup: 1,180,436 shares worth $134M. The largest sale was iShares Core S&P 500 ETF, an estimated $303M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Miscellaneous.
- Freestone Grove Partners's largest Q1 2026 buy was Citigroup: 1,180,436 shares worth $134M.
- Freestone Grove Partners added most to AXIS Capital in Q1 2026, an estimated $97.1M increase.
- Freestone Grove Partners's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $303M.
- Freestone Grove Partners fully exited Boston Scientific in Q1 2026, selling an estimated $127M.
- Freestone Grove Partners's ten largest holdings make up 19% of its $14.2B portfolio in Q1 2026.
- Freestone Grove Partners opened 515 new positions and closed 267 in Q1 2026.
- Freestone Grove Partners's portfolio value rose 2.4% quarter-over-quarter to $14.2B.
Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.